Stocktoria
Aldeyra Therapeutics, Inc. ALDX
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2014-05-02
Aldeyra Therapeutics, Inc. statistics & valuation
Market cap$110.4M
P / B2.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -47.0% | -53.4% | -25.3% | -34.2% | -24.8% |
| Return on equity | -76.5% | -78.7% | -31.3% | -41.1% | -28.1% |
| Debt / equity | 0.35× | 0.22× | 0.13× | 0.11× | 0.08× |
| Current ratio | 2.58 | 5.59 | 6.64 | 11.78 | 19.77 |
Source: SEC EDGAR filings · CIK 0001341235 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.